Studies were carried out
Monodeiodination of thyroxine (T4) leads to two alternative pathways with the formation of either its active metabolite, 3, 5, 3'-triiodothyronine (T3) or its inactive metabolite, 3, 3', 5'-tiiodothyronine (rT3). 3, 3'-diiodothyronine (T2) and other diiodinated and monoiodinated analogues are formed during the metabolism of both T3 and rT3 further downstream along the deiodinative pathways. This sequential monodeiodination of T4 and its metabolites has been demonstrated in a number of in vitro and in vivo systems, and the subject has been reviewed recently (1, 2) . Both the T3 and T2 production from T4 and rT3 require deiodination at 5'. The 5' deiodinating activities of T4 and rT3 have been reported to copurify and to have in common several assay conditions that have given rise to the theory that both of these reactions are mediated by a common 5'-deiodinating enzyme. However, a pure preparation of 5' deiodinase is not yet available (3).
At present, a number of procedures are used to assay 5' deiodinating activity. Liver, kidney and pituitary are the most commonly used enzyme sources (4-7), prepared as whole cells (8), homogenates (4-7) or microsome fractions (9). Perhaps due to these varied assay conditions, the reports on reaction kinetics and regulation of this enzymatic catalysis have shown large discrepancies (10-13). T4 or rT3 has been used as the substrate for some assays in which the reactive product T3 or T2 is measured by radioimmunossay (5, 9). In other assays, T4 or rT3 specifically labeled at 5'position with a radioactive iodine is used as the substrate and the radioiodide released during incubation is used to measure the 5'deiodinating activity (7, 8) . There is very little information on whether these varied assay systems provide comparable information on the enzyme activity or not (14, 15) .
A recent study by Visser and colleagues has called attention to the tissue specificity of 5' deiodinase and the possible existence of more than one 5' deiodinase system in the rat pituitary (16). They showed the major 5' deiodinase system in the pituitary had different substrate specificity and was more resistant to the effects of PTU and fasting than the 5' deiodinase system known in liver tissue. Other investigators have studied deiodination in placenta which had mostly 5' deiodinating activity (17). Again, information on the tissue specificity of 5' deiodinase is scarce (18). The present paper describes in detail our study of two 5' deiodinating reactions in liver and kidney tissues. The reactions were compared for their tissue specificity, substrate specificity, reaction kinetics and regulation of enzyme activity. The Vmax was 0.9pmol/mg protein/min for T4 and 222pmol/mg protein/min for rT3 deiodination. In both of our assay systems, the kidney cortex showed a higher specific activity, approximately double that of the liver. Other tissues including brain, pituitary, heart, spleen and skeletal muscle showed specific activity of 5' deiodinating activity less than 20% of the hepatic value by the T4 and less than 10% by the rT3 deiodination assay.
Regulation of 5' deiodination
The 5' deiodinating activity was influenced by a host of factors which more often influenced the two reactions to a different extent. DTE, an analogue of DTT, stimulated 5' deiodination and the enhancement reached its maximum at a DTE concentration of 0.5mM in the reaction mixture (Figure 4 ). The addition of DTE seemed to be entirely necessary for the T4 deiodinating reaction since it remained at 44% of its maximum stimulated level in the ab- competitive inhibition on the two assay systems differed quantitatively by as much as 50 times (Table 4) . At an inhibitor to substrate molar ratio of 1: 10 or more, rT3
significantly inhibited 5' deiodination of T4 by 10% of the control value. An inhibitor to substrate molar ratio of 5: 1 or more was required for T4 to reduce 5' deiodination of rT3. This competitive inhibition appeared rather specific for 5' deiodination since 3, 3'-diiodothyronine in the inhibitor to substrate molar ratio of 1: 5 did not influence either 5' deiodinating activity. Another iodinated structual analogue of T4, amiodarone, was found to be a weak inhibitor. Amiodarone reduced rT3 deiodination to 50% of the control value at an inhibitor to substrate ratio of 500: 1 or more, which approached the upper limit of its solubility in aqueous solution.
The data on the fasting effect are shown in Table 5 . Our results showed that 5' deiodination of both T4 and rT3 were reduced to 35% and 41 % of the control values, respectively, in the liver homogenate from animals which had been fasted for 24 hours. However, fasting had little effect on the 5' deiodinating activity in the kidney cortex homogenate.
In fact, when rT3 instead of T4 was used as the reaction substrate, the 5' deioninating activity of the kidney cortex increased by 21% after 24 hours and 37% after 72 hours of fasting, respectively. Our results documented a clear tissue specificity of 5' deiodinase and showed (15, 27) . However, the dependence of DTE was complete only for the 5' deiodination of rT3 while that of T4 was detectable at 45% of its maximum stimulated level in the total absence of DTE in the rat liver tissue. PTU is a noncompetitive inhibitor of iodothyronine deiodination (29). Its inhibition of 5' deiodination has been shown in a number of in vivo and in vitro systems (6, (29) (30) (31) . Our results showed that the 5' deiodination of rT3 was 100 times as sensitive to PTU inhibition as that of T4 in both liver and kidney tissues. Until now, distinct 5' deiodinating enzyme systems which are different with respect to PTU sensitivity have been reported only in studies of pituitary (15). Chopra and colleagues reported a reduction in production from T4 in the presence of 100nM of CaCl2 (5). There is no published information on the effects of other divalent ions on the 5' deiodination reaction, except that iodothyronine deiodination is enhanced in the presence of EDTA (6, 23). The T3 production from T4 was reported to increase 90% in the presence of 10mM EDTA in a rat kidney homogenate (6). Our data showed that the T4 deiodination assay was inhibited by the presence of maganese and zinc ions but not by calcium and magnesium ions in a concentration range of 0. two tissues also showed similar substrate specificity and sensitivity to PTU inhibition. However, the responses of these two tissues to fasting were different. The liver homogenate prepared from animals which had been fasted for 24 hours or longer had only 60-65% of the 5' deiodinase activity of fed animals.
In sharp contrast, the kidney homogenate prepared from these same fasted animals showed no reduction in 5' deiodinating activity when compared to the control, a property also observed in the 5' deiodinase system in the pituitary tissue (15). In fact, the 5' deiodinating activity in the kidney tissue was increased when fasting was prolonged to 72 hours.
No doubt the kidney must contribute to T3 production in a significant manner during caloric deprivation in view of its large size and high enzyme specific activity.
Therefore, our study suggests that the production of T3 from T4 is mediated by a very complex 5' deiodinating tissue specificity. Within the same tissue, multiple species of 5' deiodinase are present that are different in relation to their substrate specificity and regulation.
